Analyst Andrew Wade of Jefferies maintained a Buy rating on Pets at Home, with a price target of p265.00.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Andrew Wade has given his Buy rating due to a combination of factors tied to the Competition and Markets Authority’s final ruling on the U.K. veterinary sector, which he interprets as supportive for scaled operators like Pets at Home. The remedies are comparatively mild, broadly in line with the October draft, and where adjustments were made, such as lifting the prescription price ceiling to £21, they were made more permissive than initially proposed.
This regulatory clarity reduces uncertainty that had likely been dampening sentiment toward vet-related businesses, including constraining deal activity and operational decision‑making, and should therefore underpin more confident trading and corporate actions going forward. In Wade’s view, this backdrop benefits Pets at Home’s integrated retail‑and‑vets model, reinforcing the company’s strategic position and justifying a positive stance on the shares.
In another report released today, TipRanks – Google also upgraded the stock to a Buy with a p200.00 price target.